Ivarest Cream
NDC Package 10157-9077-1
Package Information
Ivarest (zinc oxide, benzyl alcohol, and diphenhydramine hydrochloride) cream is do not use more often than directedas soon as possible after exposure, wash affected area with soap and water (or Ivarest Poison Ivy Cleansing Foam). This formulation utilizes a cream delivery system. Marketed by Blistex Inc, this product is identified by NDC 10157-9077 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 1298467 - calamine 14 % / benzyl alcohol 10.5 % / diphenhydrAMINE HCl 2 % Topical Cream
- RxCUI: 1298467 - benzyl alcohol 0.105 ML/ML / calamine 140 MG/ML / diphenhydramine hydrochloride 20 MG/ML Topical Cream
- RxCUI: 1298467 - benzyl alcohol 10.5 % / calamine 14 % / diphenhydramine hydrochloride 2 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10157 - Blistex Inc
- 10157-9077 - Ivarest
- 10157-9077-1 - 1 TUBE in 1 CARTON / 56 g in 1 TUBE
- 10157-9077 - Ivarest
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10157-9077-1 identifies a specific commercial package of 1 tube in 1 carton / 56 g in 1 tube of Ivarest, a human over the counter drug labeled by Blistex Inc. This cream is formulated for topical use and contains benzyl alcohol; diphenhydramine hydrochloride; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Blistex Inc on December 31, 2007. The current certification is valid through December 31, 2026.
How is this Blistex Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10157907701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.